Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy.

Autor:	Yan TB; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Center for Genomics and Personalized Medicine, Guangxi Key Laboratory for Genomics and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomics and Personalized Medicine, Guangxi Medical University, Nanning, China., Huang JQ; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Center for Genomics and Personalized Medicine, Guangxi Key Laboratory for Genomics and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomics and Personalized Medicine, Guangxi Medical University, Nanning, China., Huang SY; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.; Center for Genomics and Personalized Medicine, Guangxi Key Laboratory for Genomics and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomics and Personalized Medicine, Guangxi Medical University, Nanning, China., Ahir BK; Section of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States., Li LM; Center for Genomics and Personalized Medicine, Guangxi Key Laboratory for Genomics and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomics and Personalized Medicine, Guangxi Medical University, Nanning, China., Mo ZN; Center for Genomics and Personalized Medicine, Guangxi Key Laboratory for Genomics and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomics and Personalized Medicine, Guangxi Medical University, Nanning, China., Zhong JH; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Jazyk:	angličtina
Zdroj:	Frontiers in oncology [Front Oncol] 2021 Dec 21; Vol. 11, pp. 801173. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2021).
DOI:	10.3389/fonc.2021.801173
Abstrakt:	Pancreatic cancer refers to the development of malignant tumors in the pancreas: it is associated with high mortality rates and mostly goes undetected in its early stages for lack of symptoms. Currently, surgical treatment is the only effective way to improve the survival of pancreatic cancer patients. Therefore, it is crucial to diagnose the disease as early as possible in order to improve the survival rate of patients with pancreatic cancer. Liquid biopsy is a unique in vitro diagnostic technique offering the advantage of earlier detection of tumors. Although liquid biopsies have shown promise for screening for certain cancers, whether they are effective for early diagnosis of pancreatic cancer is unclear. Therefore, we reviewed relevant literature indexed in PubMed and collated updates and information on advances in the field of liquid biopsy with respect to the early diagnosis of pancreatic cancer. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2021 Yan, Huang, Huang, Ahir, Li, Mo and Zhong.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu